findmyKOL

Anna Tavakkoli, MD

Basic profile

The University of Texas Southwestern Medical Center

ORCIDNPI
RegionDallas, TX · South CentralSpecialtyGastroenterologyFocusGastroenterology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publicationSee ScholarshipOnline presenceNot yet checkedPayments2021 onwardNIH funding2023–2026Why? →

Anna Tavakkoli is a Gastroenterology physician affiliated with The University of Texas Southwestern Medical Center. OpenAlex indexes 125 publications with 2,577 citations (h-index 19).

Overview

Scholarship

indexed output and impact (OpenAlex)
125publications

Distinct works indexed by OpenAlex, matched via ORCID.

2,577citations

Total citations across indexed works.

19h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
6companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments
1NIH grants · 2023–2026

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

5959 Harry Hines Blvd
Dallas, TX 753905362

Telephone

469-291-3372

Registry record last updated 20 Jun 2019.

View the NPPES registry record

Industry payments

6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    72.7%
    Osmotic Laxative22.2%
    Gavilyte-G72%Peg-3350 And Electrolytes28%
    Part D22 patients
    Serotonin-3 Receptor Antagonist21%
    Ondansetron Hcl100%
    Part D29 patients

    + 2 more classes in this area

  • Respiratory

    17.6%
    Opioid Agonist10.8%
    Hydrocodone-Acetaminophen100%
    Part D<11 patients
    Phenothiazine6.8%
    Promethegan100%
    Part D<11 patients
  • Sensory organs

    9.7%
    Fluoroquinolone Antibacterial9.7%
    Ciprofloxacin Hcl100%
    Part D15 patients
Where care is delivered (Part B)78.5% facility · 21.5% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

1 NIH research award on record, funded 20232026 per NIH RePORTER. The latest:

Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”